Challenging the role of retinoic acid in meiotic initiation

挑战视黄酸在减数分裂起始中的作用

基本信息

  • 批准号:
    10577875
  • 负责人:
  • 金额:
    $ 19.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Meiosis is essential for sexual reproduction, and its specialized molecular and cellular programs have been intensely studied in lower eukaryotes and mammals. In mammals, however, the transition from mitotic spermatogonia into the meiotic program, termed meiotic initiation, has received little attention. Meiotic initiation occurs during the preleptotene phase of meiotic prophase I, as these spermatocytes replicate their DNA and prepare for meiotic recombination and segregation. Retinoic acid (RA) has been proposed to serve as the ‘meiosis inducing substance.’ In the postnatal testis, although it is clearly required for spermatogonial differentiation, our exciting preliminary data reveals RA is dispensable 8.6 days later for meiotic initiation. Thus, the role of RA in meiosis has not been properly examined, and the true meiosis- inducing factor(s) remain undefined. This proposal represents a new collaboration between the Geyer and Schindler labs, who will work together to uncover the true role(s) for RA in meiosis. In Aim 1, we will identify the specific requirement for RA in initiation and progression through meiosis to form haploid spermatids. In Aim 2, we will employ a novel transgenic mouse model with synchronized spermatogenesis for fluorescence-based isolation of millions of germ cells prior to and during meiotic initiation. Using this unique resource, we will define and compare RA-mediated changes in gene expression at the transcriptome (RNA abundance), translatome (translating RNAs), and proteome (protein abundance) levels during meiotic initiation. The outcome of this work is identification of novel regulators of this critical transition, and testis-specific proteins that are upregulated in preleptotene spermatocytes will represent putative male contraceptive targets. Indeed, preleptotene spermatocytes represent an ideal cell type for male contraceptive drug development, for two reasons: 1) they reside outside the blood-testis-barrier (BTB), which is a significant barrier to drug delivery; and 2) they are distinct from the spermatogonial stem cell (SSC) pool, and thus can be targeted without irreversibly damaging the male germline. The results from this proposal will be foundational to defining the broader mechanistic relationship between RA and meiosis that are essential for male fertility.
项目总结/摘要 减数分裂是有性生殖所必需的,其专门的分子和细胞程序具有 在低等真核生物和哺乳动物中进行了深入研究。然而,在哺乳动物中, 有丝分裂的精原细胞进入减数分裂程序,称为减数分裂起始,很少受到关注。 减数分裂起始发生在减数分裂前期Ⅰ的前细线期, 复制它们DNA并为减数分裂重组和分离做准备。维甲酸(RA) 被认为是“减数分裂诱导物质”。在产后睾丸中,尽管这是明确需要的 对于精原细胞的分化,我们令人兴奋的初步数据显示RA是在8.6天后, 用于减数分裂起始。因此,RA在减数分裂中的作用尚未得到适当的研究,真正的减数分裂- 诱发因素仍未确定。该提案代表了盖耶和 辛德勒实验室,谁将共同努力,以揭示真正的作用(S)为RA在减数分裂。在目标1中,我们将确定 在减数分裂的起始和发展过程中形成单倍体精子细胞对RA的特殊要求。 在目标2中,我们将采用一种新的同步精子发生的转基因小鼠模型, 在减数分裂开始之前和期间,基于荧光的数百万生殖细胞的分离。使用此 独特的资源,我们将定义和比较RA介导的基因表达的变化, 转录组(RNA丰度)、翻译组(翻译RNA)和蛋白质组(蛋白质丰度) 在减数分裂起始阶段的水平。这项工作的结果是确定了这种关键的新的调节剂。 过渡期和睾丸特异性蛋白质在前细线期精母细胞中上调, 男性避孕目标事实上,前细线期精母细胞是一种理想的细胞类型, 男性避孕药的发展,有两个原因:1)他们居住在血液睾丸屏障外 (BTB),这是药物递送的重要屏障; 2)它们与精原干不同 细胞(SSC)池,因此可以被靶向而不会不可逆地损伤雄性生殖系。结果 从这个建议将是基础,以确定更广泛的机制之间的关系,RA和 减数分裂对男性生育力至关重要。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cnot3 is required for male germ cell development and spermatogonial stem cell maintenance.
Cnot3 是雄性生殖细胞发育和精原干细胞维持所必需的。
  • DOI:
    10.1101/2023.10.13.562256
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chen,Qing;Malki,Safia;Xu,Xiaojiang;Bennett,Brian;Lackford,BradL;Kirsanov,Oleksandr;Geyer,ChristopherB;Hu,Guang
  • 通讯作者:
    Hu,Guang
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher Bennett Geyer其他文献

Christopher Bennett Geyer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher Bennett Geyer', 18)}}的其他基金

Selecting sperm with distinct metabolic phenotypes to increase ART efficiency
选择具有不同代谢表型的精子以提高 ART 效率
  • 批准号:
    10608579
  • 财政年份:
    2023
  • 资助金额:
    $ 19.17万
  • 项目类别:
Challenging the role of retinoic acid in meiotic initiation
挑战视黄酸在减数分裂起始中的作用
  • 批准号:
    10453019
  • 财政年份:
    2022
  • 资助金额:
    $ 19.17万
  • 项目类别:
The role of retinoid exposure in specification of the foundational SSC pool
类维生素A暴露在基础SSC池规范中的作用
  • 批准号:
    9884801
  • 财政年份:
    2017
  • 资助金额:
    $ 19.17万
  • 项目类别:
The role of retinoid exposure in specification of the foundational SSC pool
类维生素A暴露在基础SSC池规范中的作用
  • 批准号:
    10112274
  • 财政年份:
    2017
  • 资助金额:
    $ 19.17万
  • 项目类别:
Translational control during fetal male germ cell development
胎儿男性生殖细胞发育过程中的翻译控制
  • 批准号:
    8287403
  • 财政年份:
    2012
  • 资助金额:
    $ 19.17万
  • 项目类别:

相似海外基金

Elucidation of the mechanisms of Blood-testis barrier permeability and reduced sperm motility by platinum nanoparticles via extracellular vesicles
阐明铂纳米颗粒通过细胞外囊泡降低血睾屏障通透性和降低精子活力的机制
  • 批准号:
    23H03548
  • 财政年份:
    2023
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Myosin VI at the blood-testis barrier
血睾屏障处的肌球蛋白 VI
  • 批准号:
    574606-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.17万
  • 项目类别:
    University Undergraduate Student Research Awards
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
睾丸网微插管的开发/验证,用于评估穿透血睾屏障的新型化学支架
  • 批准号:
    10490286
  • 财政年份:
    2021
  • 资助金额:
    $ 19.17万
  • 项目类别:
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
睾丸网微插管的开发/验证,用于评估穿透血睾屏障的新型化学支架
  • 批准号:
    10307940
  • 财政年份:
    2021
  • 资助金额:
    $ 19.17万
  • 项目类别:
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
睾丸网微插管的开发/验证,用于评估穿透血睾屏障的新型化学支架
  • 批准号:
    10924597
  • 财政年份:
    2021
  • 资助金额:
    $ 19.17万
  • 项目类别:
Characterization of Filovirus cell tropism in isolated primary cells and in a 3D blood-testis barrier co-culture model
分离原代细胞和 3D 血睾屏障共培养模型中丝状病毒细胞向性的表征
  • 批准号:
    406382
  • 财政年份:
    2018
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Studentship Programs
Structural basis of the blood-testis barrier based on structural analysis of human claudin-11.
基于人类claudin-11结构分析的血睾屏障的结构基础。
  • 批准号:
    18K06100
  • 财政年份:
    2018
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The importance of the blood-testis barrier in human infertility
血睾屏障在人类不孕症中的重要性
  • 批准号:
    nhmrc : 1124606
  • 财政年份:
    2017
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Project Grants
Circumventing the Blood-Testis Barrier
绕过血睾屏障
  • 批准号:
    9329790
  • 财政年份:
    2017
  • 资助金额:
    $ 19.17万
  • 项目类别:
The importance of the blood-testis barrier in human infertility
血睾屏障在人类不孕症中的重要性
  • 批准号:
    nhmrc : GNT1124606
  • 财政年份:
    2017
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了